Low Molecular Weight Iron Dextran — Competitive Intelligence Brief

Low Molecular Weight Iron Dextran (Low Molecular Weight Iron Dextran) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement therapy. Area: Hematology.

marketed Iron replacement therapy Hematology Small molecule

Target snapshot

Low Molecular Weight Iron Dextran (Low Molecular Weight Iron Dextran) — University of Washington. Low molecular weight iron dextran delivers iron directly into cells to replenish iron stores and treat iron deficiency anemia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Low Molecular Weight Iron Dextran TARGET	Low Molecular Weight Iron Dextran	University of Washington	marketed	Iron replacement therapy
Parentral Iron	Parentral Iron	Services Institute of Medical Sciences, Pakistan	marketed	Iron replacement therapy
Supplementation of iron sucrose	Supplementation of iron sucrose	Medical University of Vienna	marketed	Iron replacement therapy
Iron-Dextran Complex Injection [InFed]	Iron-Dextran Complex Injection [InFed]	Oregon Health and Science University	marketed	Iron replacement therapy
IV iron - Sodium Ferric Gluconate Complex	IV iron - Sodium Ferric Gluconate Complex	Rambam Health Care Campus	marketed	Iron replacement therapy	Iron (Fe3+) delivery to erythropoietic tissues
IV iron infusion	IV iron infusion	NICHD Global Network for Women's and Children's Health	marketed	Iron replacement therapy
Iron isomaltoside/ferric derisomaltose	Iron isomaltoside/ferric derisomaltose	Pharmacosmos A/S	phase 3	Iron replacement therapy	Iron metabolism pathway; ferric iron (Fe3+)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement therapy class)

1. AMAG Pharmaceuticals, Inc. · 1 drug in this class
2. Medical University of Vienna · 1 drug in this class
3. NICHD Global Network for Women's and Children's Health · 1 drug in this class
4. Nicoletta C Machin · 1 drug in this class
5. Oregon Health and Science University · 1 drug in this class
6. Pharmacosmos A/S · 1 drug in this class
7. Rambam Health Care Campus · 1 drug in this class
8. Services Institute of Medical Sciences, Pakistan · 1 drug in this class
9. Sumitomo Pharma America, Inc. · 1 drug in this class
10. University of Washington · 1 drug in this class